Evidence map›Paper›PMID 32610605›Full record

ArticleInternational journal of molecular sciences2020

β-Arrestin 2 and ERK1/2 Are Important Mediators Engaged in Close Cooperation between TRPV1 and µ-Opioid Receptors in the Plasma Membrane.

Barbora Melkes, Vendula Markova, Lucie Hejnova, Jiri Novotny

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. An analgesic peptide H-20 attenuates chronic pain via the PD-1 pathway with few adverse effects.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  4. Repeated Morphine Administration IncreasesBiomolecules & therapeutics · 2022
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Barbora MelkesDepartment of Physiology, Faculty of Science, Charles University, 128 00 Prague, Czech Republic.
Vendula MarkovaDepartment of Physiology, Faculty of Science, Charles University, 128 00 Prague, Czech Republic.
Lucie HejnovaDepartment of Physiology, Faculty of Science, Charles University, 128 00 Prague, Czech Republic.
Jiri NovotnyDepartment of Physiology, Faculty of Science, Charles University, 128 00 Prague, Czech Republic.
Charles University · CZ

Funding

Charles University, Faculty of Science SVV-260434/2020European Regional Development Fund CZ.1.05/4.1.00/16.0347Grantová Agentura, Univerzita Karlova 1196120Grantová Agentura, Univerzita Karlova 790217State Budget of the Czech Republic CZ.2.16/3.1.00/21515
6 · The paper itself

Abstract

The interactions between TRPV1 and µ-opioid receptors (MOR) have recently attracted much attention because these two receptors play important roles in pain pathways and can apparently modulate each other's functioning. However, the knowledge about signaling interactions and crosstalk between these two receptors is still limited. In this study, we investigated the mutual interactions between MOR and TRPV1 shortly after their activation in HEK293 cells expressing these two receptors. After activation of one receptor we observed significant changes in the other receptor's lateral mobility and vice versa. However, the changes in receptor movement within the plasma membrane were not connected with activation of the other receptor. We also observed that plasma membrane β-arrestin 2 levels were altered after treatment with agonists of both these receptors. Knockdown of β-arrestin 2 blocked all changes in the lateral mobility of both receptors. Furthermore, we found that β-arrestin 2 can play an important role in modulating the effectiveness of ERK1/2 phosphorylation after activation of MOR in the presence of TRPV1. These data suggest that β-arrestin 2 and ERK1/2 are important mediators between these two receptors and their signaling pathways. Collectively, MOR and TRPV1 can mutually affect each other's behavior and β-arrestin 2 apparently plays a key role in the bidirectional crosstalk between these two receptors in the plasma membrane.

Indexed as

Analgesics, OpioidArrestinsbeta-Arrestin 2beta-ArrestinsCell MembraneHEK293 CellsHumansMAP Kinase Signaling SystemMorphinePhosphorylationReceptors, OpioidReceptors, Opioid, muSignal TransductionTRPV Cation ChannelsAnalgesics, OpioidArrestinsbeta-Arrestin 2beta-ArrestinsMorphineReceptors, OpioidReceptors, Opioid, muTRPV1 protein, humanTRPV Cation Channelsbiased signalingERK1/2receptor lateral mobilityTRPV1β-arrestin 2μ-opioid receptor

Identifiers

PMID32610605
PMCPMC7370190
OpenAlexW3037118145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.